Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M165Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M165EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0.8Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

IHE is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CONDON PHILIP GPortfolio Manager 2013-11-26Buy3,000$11.751083.32 view
GABELLI MARIO JControl Person of Adviser 2013-11-26Sell35,600$21.47547.6 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$15.76782.23 view
FRIEDRICH ROMAN IIITrustee 2013-11-25Buy100$21.48547.3 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$18.19664.38 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy135$17.8681.12 view
CONDON PHILIP GPortfolio Manager 2013-11-22Buy8,500$11.81078.31 view
Dammeyer Rodney FDirector 2013-11-22Buy31,940$6.162157.14 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy107$18.06669.88 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy113$18.09668.6 view

Press Releases about IHE :

    Quarterly/Annual Reports about IHE:

      News about IHE:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Pfizer, Actavis Rumor, Inversion Turn Attention to Pharma ETFs Sep 24 2014
      ETFs for Hedge Funds’ Favorite Pharma Stocks Aug 25 2014
      The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals... Aug 25 2014
      Pharma ETF Investing 101 Aug 21 2014
      Pharma ETFs in Focus on String of Earnings Beat Jul 30 2014
      Sector Performance Update - First Half 2014 Jul 22 2014
      Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward Jul 15 2014
      Big Pharma Looks For New Models Jun 10 2014
      How Will Pfizer Treat These Healthcare ETFs? May 06 2014
      Johnson & Johnson: Why Top Funds Are Buying May 01 2014
      Merck (MRK) Earnings Beat Puts Healthcare ETFs in Focus Apr 30 2014
      Pharma ETFs: A Safe Haven from the Biotech Stock Slump? Apr 28 2014
      Investors Flee Once Hot Health Care ETFs Apr 28 2014
      Pharma ETFs: A Safe Haven from the Biotech Slump? Apr 25 2014
      Pharmaceutical ETFs Surge On M&A Activity Apr 23 2014
      Pharma ETFs: A Better Healthcare Investment? Apr 23 2014
      Pharma M&A Frenzy Pushing These ETFs Higher Apr 23 2014
      Bill Ackman Might Like These Pharma ETFs Apr 22 2014
      ModernGraham Annual Valuation Of Regeneron Pharmaceuticals Apr 16 2014
      Solid JNJ Earnings Put Healthcare ETFs in Focus Apr 16 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK